Neglected Tropical Diseases Diagnosis Market Size, Trends, Analysis, and Outlook By Disease (Dengue, Chikungunya, Rabies, Leprosy, Buruli ulcer, Yaws, Lymphatic Filariasis, Taeniasis/Cysticercosis, Foodborne trematode infections, Echinococcosis, Chagas disease, Dracunculiasis, Human African trypanosomiasis (sleeping sickness), Soil-transmitted helminthiases, Onchocerciasis, Schistosomiasis, Scabies, Snakebite Envenoming, Leishmaniases), By Diagnostic Method (Conventional Method, Molecular/Modern Method), By Service (Centralized Service, POC Service), By End-user (Clinical Labs, Hospitals /Clinics, Home Healthcare), by Region, Country, Segment, and Companies, 2024-2030
The global Neglected Tropical Diseases Diagnosis market size is poised to register 4.66% growth from 2024 to 2030, presenting significant growth prospects for companies operating in the industry. The industry study analyzes the global Neglected Tropical Diseases Diagnosis market across By Disease (Dengue, Chikungunya, Rabies, Leprosy, Buruli ulcer, Yaws, Lymphatic Filariasis, Taeniasis/Cysticercosis, Foodborne trematode infections, Echinococcosis, Chagas disease, Dracunculiasis, Human African trypanosomiasis (sleeping sickness), Soil-transmitted helminthiases, Onchocerciasis, Schistosomiasis, Scabies, Snakebite Envenoming, Leishmaniases), By Diagnostic Method (Conventional Method, Molecular/Modern Method), By Service (Centralized Service, POC Service), By End-user (Clinical Labs, Hospitals /Clinics, Home Healthcare).
The Neglected Tropical Diseases Diagnosis Market is witnessing growth driven by the global efforts to control and eliminate neglected tropical diseases (NTDs), such as malaria, dengue fever, Chagas disease, and leishmaniasis, through improved disease surveillance, early detection, and access to diagnostic testing. Neglected tropical diseases disproportionately affect low-income and resource-limited regions, posing significant public health challenges and socioeconomic burdens. Key trends shaping its future include the development of rapid diagnostic tests (RDTs) and point-of-care (POC) assays for decentralized and community-based screening and surveillance of NTDs in endemic areas with limited healthcare infrastructure, the integration of multiplex and molecular diagnostic technologies for simultaneous detection of multiple NTD pathogens and co-infections, and the customization of diagnostic algorithms and surveillance strategies to address specific disease epidemiologies, transmission dynamics, and control priorities. Moreover, factors such as the investments in NTD research and development, the collaborations between governments, non-profit organizations, and pharmaceutical companies, and the initiatives for universal health coverage and global health security are expected to drive market growth in 2024 and beyond.
Neglected Tropical Diseases Diagnosis Market Drivers, Trends, Opportunities, and Growth Opportunities
This comprehensive study discusses the latest trends and the most pressing challenges for industry players and investors. The Neglected Tropical Diseases Diagnosis market research analyses the global market trends, key drivers, challenges, and opportunities in the industry. In addition, the latest Future of Neglected Tropical Diseases Diagnosis survey report provides the market size outlook across types, applications, and other segments across the world and regions. It provides data-driven insights and actionable recommendations for companies in the Neglected Tropical Diseases Diagnosis industry.
Key market trends defining the global Neglected Tropical Diseases Diagnosis demand in 2024 and Beyond
The industry continues to remain an attractive hub for opportunities for both domestic and global vendors. As the market evolves, factors such as emerging market dynamics, demand from end-user sectors, a growing patient base, changes in consumption patterns, and widening distribution channels continue to play a major role.
Neglected Tropical Diseases Diagnosis Market Segmentation- Industry Share, Market Size, and Outlook to 2030
The Neglected Tropical Diseases Diagnosis industry comprises a wide range of segments and sub-segments. The rising demand for these product types and applications is supporting companies to increase their investment levels across niche segments. Accordingly, leading companies plan to generate a large share of their future revenue growth from expansion into these niche segments. The report presents the market size outlook across segments to support Neglected Tropical Diseases Diagnosis companies scaling up production in these sub-segments with a focus on expanding into emerging countries.
Key strategies adopted by companies within the Neglected Tropical Diseases Diagnosis industry
Leading Neglected Tropical Diseases Diagnosis companies are boosting investments to capitalize on untapped potential and future possibilities across niche market segments and surging demand conditions in key regions. Further, companies are leveraging advanced technologies to unlock opportunities and achieve operational excellence. The report provides key strategies opted for by the top 10 Neglected Tropical Diseases Diagnosis companies.
Neglected Tropical Diseases Diagnosis Market Study- Strategic Analysis Review
The Neglected Tropical Diseases Diagnosis market research report dives deep into the qualitative factors shaping the market, empowering you to make informed decisions-
The Neglected Tropical Diseases Diagnosis industry report provides a detailed analysis and outlook of revenue generated by companies from 2018 to 2023. Further, with actual data for 2023, the report forecasts the market size outlook from 2024 to 2030 in three case scenarios- low case, reference case, and high case scenarios.
Neglected Tropical Diseases Diagnosis Country Analysis and Revenue Outlook to 2030
The report analyses 22 countries worldwide including the key driving forces and market size outlook from 2021 to 2030. In addition, region analysis across Asia Pacific, Europe, the Middle East, Africa, North America, and South America is included in the study. For each of the six regions, the market size outlook by segments is forecast for 2030.
North America Neglected Tropical Diseases Diagnosis Market Size Outlook- Companies plan for focused investments in a changing environment
The US continues to remain the market leader in North America, driven by a large consumer base, the presence of well-established providers, and a strong end-user industry demand. Leading companies focus on new product launches in the changing environment. The US economy is expected to grow in 2024 (around 2.2% growth in 2024), potentially driving demand for various Neglected Tropical Diseases Diagnosis market segments. Similarly, Strong end-user demand is encouraging Canadian Neglected Tropical Diseases Diagnosis companies to invest in niche segments. Further, as Mexico continues to strengthen its trade relations and invest in technological advancements, the Mexico Neglected Tropical Diseases Diagnosis market is expected to experience significant expansion, offering lucrative opportunities for both domestic and international stakeholders.
Europe Neglected Tropical Diseases Diagnosis Market Size Outlook-Companies investing in assessing consumers, categories, competitors, and capabilities
The German industry remains the major market for companies in the European Neglected Tropical Diseases Diagnosis industry with consumers in Germany, France, the UK, Spain, Italy, and others anticipated to register a steady demand throughout the forecast period, driving the overall market prospects. In addition, the proactive approach of businesses in identifying and leveraging new growth prospects positions the European Neglected Tropical Diseases Diagnosis market for an upward trajectory, fostering both domestic and international interest. Leading brands operating in the industry are emphasizing effective marketing strategies, innovative product offerings, and a keen understanding of consumer preferences.
Asia Pacific Neglected Tropical Diseases Diagnosis Market Size Outlook- an attractive hub for opportunities for both local and global companies
The increasing prevalence of indications, robust healthcare expenditure, and increasing investments in healthcare infrastructure drive the demand for Neglected Tropical Diseases Diagnosis in Asia Pacific. In particular, China, India, and South East Asian Neglected Tropical Diseases Diagnosis markets present a compelling outlook for 2030, acting as a magnet for both domestic and multinational manufacturers seeking growth opportunities. Similarly, with a burgeoning population and a rising middle class, India offers a vast consumer market. Japanese and Korean companies are quickly aligning their strategies to navigate changes, explore new markets, and enhance their competitive edge. Our report utilizes in-depth interviews with industry experts and comprehensive data analysis to provide a comprehensive outlook of 6 major markets in the region.
Latin America Neglected Tropical Diseases Diagnosis Market Size Outlook- Continued urbanization and rising income levels
Rising income levels contribute to greater purchasing power among consumers, spurring consumption and creating opportunities for market expansion. Continued urbanization and rising income levels are expected to sustainably drive consumption growth in the medium to long term.
Middle East and Africa Neglected Tropical Diseases Diagnosis Market Size Outlook- continues its upward trajectory across segments
Robust demand from Middle Eastern countries including Saudi Arabia, the UAE, Qatar, Kuwait, and other GCC countries supports the overall Middle East Neglected Tropical Diseases Diagnosis market potential. Fueled by increasing healthcare expenditure of individuals, growing population, and high prevalence across a few markets drives the demand for Neglected Tropical Diseases Diagnosis.
Neglected Tropical Diseases Diagnosis Market Company Profiles
The global Neglected Tropical Diseases Diagnosis market is characterized by intense competitive conditions with leading companies opting for aggressive marketing to gain market shares. The report presents business descriptions, SWOT analysis, growth strategies, and financial profiles. Leading companies included in the study are Abbott, Coris BioConcept, DiaSys Diagnostic Systems GmbH, F. Hoffmann-La Roche Ltd, Genome Diagnostics Pvt Ltd, InBios International Inc, Omega Diagnostics Group PLC, Oscar Medicare Pvt Ltd, Thermo Fisher Scientific Inc, ZeptoMetrix
Recent Neglected Tropical Diseases Diagnosis Market Developments
The global Neglected Tropical Diseases Diagnosis market study presents recent market news and developments including new product launches, mergers, acquisitions, expansions, product approvals, and other updates in the industry.
Neglected Tropical Diseases Diagnosis Market Report Scope
Parameters: Revenue, Volume Price
Study Period: 2023 (Base Year); 2018- 2023 (Historic Period); 2024- 2030 (Forecast Period)
Currency: USD; (Upon request, can be provided in Euro, JPY, GBP, and other Local Currency)
Qualitative Analysis
By Disease
Dengue
Chikungunya
Rabies
Leprosy
Buruli ulcer
Yaws
Lymphatic Filariasis
Taeniasis/Cysticercosis
Foodborne trematode infections
Echinococcosis
Chagas disease
Dracunculiasis
Human African trypanosomiasis (sleeping sickness)
Soil-transmitted helminthiases
Onchocerciasis
Schistosomiasis
Scabies
Snakebite Envenoming
Leishmaniases
By Diagnostic Method
Conventional Method
Molecular/Modern Method
By Service
Centralized Service
POC Service
By End-user
Clinical Labs
Hospitals /Clinics
Home Healthcare
Geographical Segmentation:
Abbott
Coris BioConcept
DiaSys Diagnostic Systems GmbH
F. Hoffmann-La Roche Ltd
Genome Diagnostics Pvt Ltd
InBios International Inc
Omega Diagnostics Group PLC
Oscar Medicare Pvt Ltd
Thermo Fisher Scientific Inc
ZeptoMetrix
Formats Available: Excel, PDF, and PPT
The Neglected Tropical Diseases Diagnosis Market is witnessing growth driven by the global efforts to control and eliminate neglected tropical diseases (NTDs), such as malaria, dengue fever, Chagas disease, and leishmaniasis, through improved disease surveillance, early detection, and access to diagnostic testing. Neglected tropical diseases disproportionately affect low-income and resource-limited regions, posing significant public health challenges and socioeconomic burdens. Key trends shaping its future include the development of rapid diagnostic tests (RDTs) and point-of-care (POC) assays for decentralized and community-based screening and surveillance of NTDs in endemic areas with limited healthcare infrastructure, the integration of multiplex and molecular diagnostic technologies for simultaneous detection of multiple NTD pathogens and co-infections, and the customization of diagnostic algorithms and surveillance strategies to address specific disease epidemiologies, transmission dynamics, and control priorities. Moreover, factors such as the investments in NTD research and development, the collaborations between governments, non-profit organizations, and pharmaceutical companies, and the initiatives for universal health coverage and global health security are expected to drive market growth in 2024 and beyond.
Neglected Tropical Diseases Diagnosis Market Drivers, Trends, Opportunities, and Growth Opportunities
This comprehensive study discusses the latest trends and the most pressing challenges for industry players and investors. The Neglected Tropical Diseases Diagnosis market research analyses the global market trends, key drivers, challenges, and opportunities in the industry. In addition, the latest Future of Neglected Tropical Diseases Diagnosis survey report provides the market size outlook across types, applications, and other segments across the world and regions. It provides data-driven insights and actionable recommendations for companies in the Neglected Tropical Diseases Diagnosis industry.
Key market trends defining the global Neglected Tropical Diseases Diagnosis demand in 2024 and Beyond
The industry continues to remain an attractive hub for opportunities for both domestic and global vendors. As the market evolves, factors such as emerging market dynamics, demand from end-user sectors, a growing patient base, changes in consumption patterns, and widening distribution channels continue to play a major role.
Neglected Tropical Diseases Diagnosis Market Segmentation- Industry Share, Market Size, and Outlook to 2030
The Neglected Tropical Diseases Diagnosis industry comprises a wide range of segments and sub-segments. The rising demand for these product types and applications is supporting companies to increase their investment levels across niche segments. Accordingly, leading companies plan to generate a large share of their future revenue growth from expansion into these niche segments. The report presents the market size outlook across segments to support Neglected Tropical Diseases Diagnosis companies scaling up production in these sub-segments with a focus on expanding into emerging countries.
Key strategies adopted by companies within the Neglected Tropical Diseases Diagnosis industry
Leading Neglected Tropical Diseases Diagnosis companies are boosting investments to capitalize on untapped potential and future possibilities across niche market segments and surging demand conditions in key regions. Further, companies are leveraging advanced technologies to unlock opportunities and achieve operational excellence. The report provides key strategies opted for by the top 10 Neglected Tropical Diseases Diagnosis companies.
Neglected Tropical Diseases Diagnosis Market Study- Strategic Analysis Review
The Neglected Tropical Diseases Diagnosis market research report dives deep into the qualitative factors shaping the market, empowering you to make informed decisions-
- Industry Dynamics: Porter's Five Forces analysis to understand bargaining power, competitive rivalry, and threats that impact long-term strategy formulation.
- Strategic Insights: Provides valuable perspectives on key players and their approaches based on comprehensive strategy analysis.
- Internal Strengths and Weaknesses: Develop targeted strategies to leverage strengths, address weaknesses, and capitalize on market opportunities.
- Future Possibilities: Prepare for diverse outcomes with in-depth scenario analysis. Explore potential market disruptions, technology advancements, and economic changes.
The Neglected Tropical Diseases Diagnosis industry report provides a detailed analysis and outlook of revenue generated by companies from 2018 to 2023. Further, with actual data for 2023, the report forecasts the market size outlook from 2024 to 2030 in three case scenarios- low case, reference case, and high case scenarios.
Neglected Tropical Diseases Diagnosis Country Analysis and Revenue Outlook to 2030
The report analyses 22 countries worldwide including the key driving forces and market size outlook from 2021 to 2030. In addition, region analysis across Asia Pacific, Europe, the Middle East, Africa, North America, and South America is included in the study. For each of the six regions, the market size outlook by segments is forecast for 2030.
North America Neglected Tropical Diseases Diagnosis Market Size Outlook- Companies plan for focused investments in a changing environment
The US continues to remain the market leader in North America, driven by a large consumer base, the presence of well-established providers, and a strong end-user industry demand. Leading companies focus on new product launches in the changing environment. The US economy is expected to grow in 2024 (around 2.2% growth in 2024), potentially driving demand for various Neglected Tropical Diseases Diagnosis market segments. Similarly, Strong end-user demand is encouraging Canadian Neglected Tropical Diseases Diagnosis companies to invest in niche segments. Further, as Mexico continues to strengthen its trade relations and invest in technological advancements, the Mexico Neglected Tropical Diseases Diagnosis market is expected to experience significant expansion, offering lucrative opportunities for both domestic and international stakeholders.
Europe Neglected Tropical Diseases Diagnosis Market Size Outlook-Companies investing in assessing consumers, categories, competitors, and capabilities
The German industry remains the major market for companies in the European Neglected Tropical Diseases Diagnosis industry with consumers in Germany, France, the UK, Spain, Italy, and others anticipated to register a steady demand throughout the forecast period, driving the overall market prospects. In addition, the proactive approach of businesses in identifying and leveraging new growth prospects positions the European Neglected Tropical Diseases Diagnosis market for an upward trajectory, fostering both domestic and international interest. Leading brands operating in the industry are emphasizing effective marketing strategies, innovative product offerings, and a keen understanding of consumer preferences.
Asia Pacific Neglected Tropical Diseases Diagnosis Market Size Outlook- an attractive hub for opportunities for both local and global companies
The increasing prevalence of indications, robust healthcare expenditure, and increasing investments in healthcare infrastructure drive the demand for Neglected Tropical Diseases Diagnosis in Asia Pacific. In particular, China, India, and South East Asian Neglected Tropical Diseases Diagnosis markets present a compelling outlook for 2030, acting as a magnet for both domestic and multinational manufacturers seeking growth opportunities. Similarly, with a burgeoning population and a rising middle class, India offers a vast consumer market. Japanese and Korean companies are quickly aligning their strategies to navigate changes, explore new markets, and enhance their competitive edge. Our report utilizes in-depth interviews with industry experts and comprehensive data analysis to provide a comprehensive outlook of 6 major markets in the region.
Latin America Neglected Tropical Diseases Diagnosis Market Size Outlook- Continued urbanization and rising income levels
Rising income levels contribute to greater purchasing power among consumers, spurring consumption and creating opportunities for market expansion. Continued urbanization and rising income levels are expected to sustainably drive consumption growth in the medium to long term.
Middle East and Africa Neglected Tropical Diseases Diagnosis Market Size Outlook- continues its upward trajectory across segments
Robust demand from Middle Eastern countries including Saudi Arabia, the UAE, Qatar, Kuwait, and other GCC countries supports the overall Middle East Neglected Tropical Diseases Diagnosis market potential. Fueled by increasing healthcare expenditure of individuals, growing population, and high prevalence across a few markets drives the demand for Neglected Tropical Diseases Diagnosis.
Neglected Tropical Diseases Diagnosis Market Company Profiles
The global Neglected Tropical Diseases Diagnosis market is characterized by intense competitive conditions with leading companies opting for aggressive marketing to gain market shares. The report presents business descriptions, SWOT analysis, growth strategies, and financial profiles. Leading companies included in the study are Abbott, Coris BioConcept, DiaSys Diagnostic Systems GmbH, F. Hoffmann-La Roche Ltd, Genome Diagnostics Pvt Ltd, InBios International Inc, Omega Diagnostics Group PLC, Oscar Medicare Pvt Ltd, Thermo Fisher Scientific Inc, ZeptoMetrix
Recent Neglected Tropical Diseases Diagnosis Market Developments
The global Neglected Tropical Diseases Diagnosis market study presents recent market news and developments including new product launches, mergers, acquisitions, expansions, product approvals, and other updates in the industry.
Neglected Tropical Diseases Diagnosis Market Report Scope
Parameters: Revenue, Volume Price
Study Period: 2023 (Base Year); 2018- 2023 (Historic Period); 2024- 2030 (Forecast Period)
Currency: USD; (Upon request, can be provided in Euro, JPY, GBP, and other Local Currency)
Qualitative Analysis
- Pricing Analysis
- Value Chain Analysis
- SWOT Profile
- Market Dynamics- Trends, Drivers, Challenges
- Porter’s Five Forces Analysis
- Macroeconomic Impact Analysis
- Case Scenarios- Low, Base, High
By Disease
Dengue
Chikungunya
Rabies
Leprosy
Buruli ulcer
Yaws
Lymphatic Filariasis
Taeniasis/Cysticercosis
Foodborne trematode infections
Echinococcosis
Chagas disease
Dracunculiasis
Human African trypanosomiasis (sleeping sickness)
Soil-transmitted helminthiases
Onchocerciasis
Schistosomiasis
Scabies
Snakebite Envenoming
Leishmaniases
By Diagnostic Method
Conventional Method
Molecular/Modern Method
By Service
Centralized Service
POC Service
By End-user
Clinical Labs
Hospitals /Clinics
Home Healthcare
Geographical Segmentation:
- North America (3 markets)
- Europe (6 markets)
- Asia Pacific (6 markets)
- Latin America (3 markets)
- Middle East Africa (5 markets)
Abbott
Coris BioConcept
DiaSys Diagnostic Systems GmbH
F. Hoffmann-La Roche Ltd
Genome Diagnostics Pvt Ltd
InBios International Inc
Omega Diagnostics Group PLC
Oscar Medicare Pvt Ltd
Thermo Fisher Scientific Inc
ZeptoMetrix
Formats Available: Excel, PDF, and PPT
1. EXECUTIVE SUMMARY
1.1 Neglected Tropical Diseases Diagnosis Market Overview and Key Findings, 2024
1.2 Neglected Tropical Diseases Diagnosis Market Size and Growth Outlook, 2021- 2030
1.3 Neglected Tropical Diseases Diagnosis Market Growth Opportunities to 2030
1.4 Key Neglected Tropical Diseases Diagnosis Market Trends and Challenges
1.4.1 Neglected Tropical Diseases Diagnosis Market Drivers and Trends
1.4.2 Neglected Tropical Diseases Diagnosis Market Challenges
1.5 Competitive Landscape and Key Players
1.6 Competitive Analysis- Growth Strategies Adopted by Leading Neglected Tropical Diseases Diagnosis Companies
2. NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE OUTLOOK TO 2030
2.1 Neglected Tropical Diseases Diagnosis Market Size Outlook, USD Million, 2021- 2030
2.2 Neglected Tropical Diseases Diagnosis Incremental Market Growth Outlook, %, 2021- 2030
2.3 Segment Snapshot, 2024
3. NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET- STRATEGIC ANALYSIS REVIEW
3.1 Porter's Five Forces Analysis
* Threat of New Entrants
* Threat of Substitutes
* Intensity of Competitive Rivalry
* Bargaining Power of Buyers
* Bargaining Power of Suppliers
3.2 Value Chain Analysis
3.3 SWOT Analysis
4. NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SEGMENTATION ANALYSIS AND OUTLOOK
4.1 Market Segmentation and Scope
4.2 Market Breakdown by Type, Application, and Other Segments, 2021-2030
By Disease
Dengue
Chikungunya
Rabies
Leprosy
Buruli ulcer
Yaws
Lymphatic Filariasis
Taeniasis/Cysticercosis
Foodborne trematode infections
Echinococcosis
Chagas disease
Dracunculiasis
Human African trypanosomiasis (sleeping sickness)
Soil-transmitted helminthiases
Onchocerciasis
Schistosomiasis
Scabies
Snakebite Envenoming
Leishmaniases
By Diagnostic Method
Conventional Method
Molecular/Modern Method
By Service
Centralized Service
POC Service
By End-user
Clinical Labs
Hospitals /Clinics
Home Healthcare
4.3 Growth Prospects and Niche Opportunities, 2023- 2030
4.4 Regional comparison of Market Growth, CAGR, 2023-2030
5. REGION-WISE MARKET OUTLOOK TO 2030
5.1 Key Findings for Asia Pacific Neglected Tropical Diseases Diagnosis Market, 2025
5.2 Asia Pacific Neglected Tropical Diseases Diagnosis Market Size Outlook by Type, 2021- 2030
5.3 Asia Pacific Neglected Tropical Diseases Diagnosis Market Size Outlook by Application, 2021- 2030
5.4 Key Findings for Europe Neglected Tropical Diseases Diagnosis Market, 2025
5.5 Europe Neglected Tropical Diseases Diagnosis Market Size Outlook by Type, 2021- 2030
5.6 Europe Neglected Tropical Diseases Diagnosis Market Size Outlook by Application, 2021- 2030
5.7 Key Findings for North America Neglected Tropical Diseases Diagnosis Market, 2025
5.8 North America Neglected Tropical Diseases Diagnosis Market Size Outlook by Type, 2021- 2030
5.9 North America Neglected Tropical Diseases Diagnosis Market Size Outlook by Application, 2021- 2030
5.10 Key Findings for South America Neglected Tropical Diseases Diagnosis Market, 2025
5.11 South America Pacific Neglected Tropical Diseases Diagnosis Market Size Outlook by Type, 2021- 2030
5.12 South America Neglected Tropical Diseases Diagnosis Market Size Outlook by Application, 2021- 2030
5.13 Key Findings for Middle East and Africa Neglected Tropical Diseases Diagnosis Market, 2025
5.14 Middle East Africa Neglected Tropical Diseases Diagnosis Market Size Outlook by Type, 2021- 2030
5.15 Middle East Africa Neglected Tropical Diseases Diagnosis Market Size Outlook by Application, 2021- 2030
6. COUNTRY-WISE MARKET SIZE OUTLOOK TO 2030
6.1 US Neglected Tropical Diseases Diagnosis Market Size Outlook and Revenue Growth Forecasts
6.2 US Neglected Tropical Diseases Diagnosis Industry Drivers and Opportunities
6.3 Canada Market Size Outlook and Revenue Growth Forecasts
6.4 Canada Neglected Tropical Diseases Diagnosis Industry Drivers and Opportunities
6.6 Mexico Market Size Outlook and Revenue Growth Forecasts
6.6 Mexico Neglected Tropical Diseases Diagnosis Industry Drivers and Opportunities
6.7 Germany Market Size Outlook and Revenue Growth Forecasts
6.8 Germany Neglected Tropical Diseases Diagnosis Industry Drivers and Opportunities
6.9 France Market Size Outlook and Revenue Growth Forecasts
6.10 France Neglected Tropical Diseases Diagnosis Industry Drivers and Opportunities
6.11 UK Market Size Outlook and Revenue Growth Forecasts
6.12 UK Neglected Tropical Diseases Diagnosis Industry Drivers and Opportunities
6.13 Spain Market Size Outlook and Revenue Growth Forecasts
6.14 Spain Neglected Tropical Diseases Diagnosis Industry Drivers and Opportunities
6.16 Italy Market Size Outlook and Revenue Growth Forecasts
6.16 Italy Neglected Tropical Diseases Diagnosis Industry Drivers and Opportunities
6.17 Rest of Europe Market Size Outlook and Revenue Growth Forecasts
6.18 Rest of Europe Neglected Tropical Diseases Diagnosis Industry Drivers and Opportunities
6.19 China Market Size Outlook and Revenue Growth Forecasts
6.20 China Neglected Tropical Diseases Diagnosis Industry Drivers and Opportunities
6.21 India Market Size Outlook and Revenue Growth Forecasts
6.22 India Neglected Tropical Diseases Diagnosis Industry Drivers and Opportunities
6.23 Japan Market Size Outlook and Revenue Growth Forecasts
6.24 Japan Neglected Tropical Diseases Diagnosis Industry Drivers and Opportunities
6.26 South Korea Market Size Outlook and Revenue Growth Forecasts
6.26 South Korea Neglected Tropical Diseases Diagnosis Industry Drivers and Opportunities
6.27 Australia Market Size Outlook and Revenue Growth Forecasts
6.28 Australia Neglected Tropical Diseases Diagnosis Industry Drivers and Opportunities
6.29 South East Asia Market Size Outlook and Revenue Growth Forecasts
6.30 South East Asia Neglected Tropical Diseases Diagnosis Industry Drivers and Opportunities
6.31 Rest of Asia Pacific Market Size Outlook and Revenue Growth Forecasts
6.32 Rest of Asia Pacific Neglected Tropical Diseases Diagnosis Industry Drivers and Opportunities
6.33 Brazil Market Size Outlook and Revenue Growth Forecasts
6.34 Brazil Neglected Tropical Diseases Diagnosis Industry Drivers and Opportunities
6.36 Argentina Market Size Outlook and Revenue Growth Forecasts
6.36 Argentina Neglected Tropical Diseases Diagnosis Industry Drivers and Opportunities
6.37 Rest of South America Market Size Outlook and Revenue Growth Forecasts
6.38 Rest of South America Neglected Tropical Diseases Diagnosis Industry Drivers and Opportunities
6.39 Middle East Market Size Outlook and Revenue Growth Forecasts
6.40 Middle East Neglected Tropical Diseases Diagnosis Industry Drivers and Opportunities
6.41 Africa Market Size Outlook and Revenue Growth Forecasts
6.42 Africa Neglected Tropical Diseases Diagnosis Industry Drivers and Opportunities
7. NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET OUTLOOK ACROSS SCENARIOS
7.1 Low Growth Case
7.2 Reference Growth Case
7.3 High Growth Case
8. NEGLECTED TROPICAL DISEASES DIAGNOSIS COMPANY PROFILES
8.1 Profiles of Leading Neglected Tropical Diseases Diagnosis Companies in the Market
8.2 Business Descriptions, SWOT Analysis, and Growth Strategies
8.3 Financial Performance and Key Metrics
Abbott
Coris BioConcept
DiaSys Diagnostic Systems GmbH
F. Hoffmann-La Roche Ltd
Genome Diagnostics Pvt Ltd
InBios International Inc
Omega Diagnostics Group PLC
Oscar Medicare Pvt Ltd
Thermo Fisher Scientific Inc
ZeptoMetrix
9. APPENDIX
9.1 Scope of the Report
9.2 Research Methodology and Data Sources
9.3 Glossary of Terms
9.4 Market Definitions
9.5 Contact Information
1.1 Neglected Tropical Diseases Diagnosis Market Overview and Key Findings, 2024
1.2 Neglected Tropical Diseases Diagnosis Market Size and Growth Outlook, 2021- 2030
1.3 Neglected Tropical Diseases Diagnosis Market Growth Opportunities to 2030
1.4 Key Neglected Tropical Diseases Diagnosis Market Trends and Challenges
1.4.1 Neglected Tropical Diseases Diagnosis Market Drivers and Trends
1.4.2 Neglected Tropical Diseases Diagnosis Market Challenges
1.5 Competitive Landscape and Key Players
1.6 Competitive Analysis- Growth Strategies Adopted by Leading Neglected Tropical Diseases Diagnosis Companies
2. NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SIZE OUTLOOK TO 2030
2.1 Neglected Tropical Diseases Diagnosis Market Size Outlook, USD Million, 2021- 2030
2.2 Neglected Tropical Diseases Diagnosis Incremental Market Growth Outlook, %, 2021- 2030
2.3 Segment Snapshot, 2024
3. NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET- STRATEGIC ANALYSIS REVIEW
3.1 Porter's Five Forces Analysis
* Threat of New Entrants
* Threat of Substitutes
* Intensity of Competitive Rivalry
* Bargaining Power of Buyers
* Bargaining Power of Suppliers
3.2 Value Chain Analysis
3.3 SWOT Analysis
4. NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET SEGMENTATION ANALYSIS AND OUTLOOK
4.1 Market Segmentation and Scope
4.2 Market Breakdown by Type, Application, and Other Segments, 2021-2030
By Disease
Dengue
Chikungunya
Rabies
Leprosy
Buruli ulcer
Yaws
Lymphatic Filariasis
Taeniasis/Cysticercosis
Foodborne trematode infections
Echinococcosis
Chagas disease
Dracunculiasis
Human African trypanosomiasis (sleeping sickness)
Soil-transmitted helminthiases
Onchocerciasis
Schistosomiasis
Scabies
Snakebite Envenoming
Leishmaniases
By Diagnostic Method
Conventional Method
Molecular/Modern Method
By Service
Centralized Service
POC Service
By End-user
Clinical Labs
Hospitals /Clinics
Home Healthcare
4.3 Growth Prospects and Niche Opportunities, 2023- 2030
4.4 Regional comparison of Market Growth, CAGR, 2023-2030
5. REGION-WISE MARKET OUTLOOK TO 2030
5.1 Key Findings for Asia Pacific Neglected Tropical Diseases Diagnosis Market, 2025
5.2 Asia Pacific Neglected Tropical Diseases Diagnosis Market Size Outlook by Type, 2021- 2030
5.3 Asia Pacific Neglected Tropical Diseases Diagnosis Market Size Outlook by Application, 2021- 2030
5.4 Key Findings for Europe Neglected Tropical Diseases Diagnosis Market, 2025
5.5 Europe Neglected Tropical Diseases Diagnosis Market Size Outlook by Type, 2021- 2030
5.6 Europe Neglected Tropical Diseases Diagnosis Market Size Outlook by Application, 2021- 2030
5.7 Key Findings for North America Neglected Tropical Diseases Diagnosis Market, 2025
5.8 North America Neglected Tropical Diseases Diagnosis Market Size Outlook by Type, 2021- 2030
5.9 North America Neglected Tropical Diseases Diagnosis Market Size Outlook by Application, 2021- 2030
5.10 Key Findings for South America Neglected Tropical Diseases Diagnosis Market, 2025
5.11 South America Pacific Neglected Tropical Diseases Diagnosis Market Size Outlook by Type, 2021- 2030
5.12 South America Neglected Tropical Diseases Diagnosis Market Size Outlook by Application, 2021- 2030
5.13 Key Findings for Middle East and Africa Neglected Tropical Diseases Diagnosis Market, 2025
5.14 Middle East Africa Neglected Tropical Diseases Diagnosis Market Size Outlook by Type, 2021- 2030
5.15 Middle East Africa Neglected Tropical Diseases Diagnosis Market Size Outlook by Application, 2021- 2030
6. COUNTRY-WISE MARKET SIZE OUTLOOK TO 2030
6.1 US Neglected Tropical Diseases Diagnosis Market Size Outlook and Revenue Growth Forecasts
6.2 US Neglected Tropical Diseases Diagnosis Industry Drivers and Opportunities
6.3 Canada Market Size Outlook and Revenue Growth Forecasts
6.4 Canada Neglected Tropical Diseases Diagnosis Industry Drivers and Opportunities
6.6 Mexico Market Size Outlook and Revenue Growth Forecasts
6.6 Mexico Neglected Tropical Diseases Diagnosis Industry Drivers and Opportunities
6.7 Germany Market Size Outlook and Revenue Growth Forecasts
6.8 Germany Neglected Tropical Diseases Diagnosis Industry Drivers and Opportunities
6.9 France Market Size Outlook and Revenue Growth Forecasts
6.10 France Neglected Tropical Diseases Diagnosis Industry Drivers and Opportunities
6.11 UK Market Size Outlook and Revenue Growth Forecasts
6.12 UK Neglected Tropical Diseases Diagnosis Industry Drivers and Opportunities
6.13 Spain Market Size Outlook and Revenue Growth Forecasts
6.14 Spain Neglected Tropical Diseases Diagnosis Industry Drivers and Opportunities
6.16 Italy Market Size Outlook and Revenue Growth Forecasts
6.16 Italy Neglected Tropical Diseases Diagnosis Industry Drivers and Opportunities
6.17 Rest of Europe Market Size Outlook and Revenue Growth Forecasts
6.18 Rest of Europe Neglected Tropical Diseases Diagnosis Industry Drivers and Opportunities
6.19 China Market Size Outlook and Revenue Growth Forecasts
6.20 China Neglected Tropical Diseases Diagnosis Industry Drivers and Opportunities
6.21 India Market Size Outlook and Revenue Growth Forecasts
6.22 India Neglected Tropical Diseases Diagnosis Industry Drivers and Opportunities
6.23 Japan Market Size Outlook and Revenue Growth Forecasts
6.24 Japan Neglected Tropical Diseases Diagnosis Industry Drivers and Opportunities
6.26 South Korea Market Size Outlook and Revenue Growth Forecasts
6.26 South Korea Neglected Tropical Diseases Diagnosis Industry Drivers and Opportunities
6.27 Australia Market Size Outlook and Revenue Growth Forecasts
6.28 Australia Neglected Tropical Diseases Diagnosis Industry Drivers and Opportunities
6.29 South East Asia Market Size Outlook and Revenue Growth Forecasts
6.30 South East Asia Neglected Tropical Diseases Diagnosis Industry Drivers and Opportunities
6.31 Rest of Asia Pacific Market Size Outlook and Revenue Growth Forecasts
6.32 Rest of Asia Pacific Neglected Tropical Diseases Diagnosis Industry Drivers and Opportunities
6.33 Brazil Market Size Outlook and Revenue Growth Forecasts
6.34 Brazil Neglected Tropical Diseases Diagnosis Industry Drivers and Opportunities
6.36 Argentina Market Size Outlook and Revenue Growth Forecasts
6.36 Argentina Neglected Tropical Diseases Diagnosis Industry Drivers and Opportunities
6.37 Rest of South America Market Size Outlook and Revenue Growth Forecasts
6.38 Rest of South America Neglected Tropical Diseases Diagnosis Industry Drivers and Opportunities
6.39 Middle East Market Size Outlook and Revenue Growth Forecasts
6.40 Middle East Neglected Tropical Diseases Diagnosis Industry Drivers and Opportunities
6.41 Africa Market Size Outlook and Revenue Growth Forecasts
6.42 Africa Neglected Tropical Diseases Diagnosis Industry Drivers and Opportunities
7. NEGLECTED TROPICAL DISEASES DIAGNOSIS MARKET OUTLOOK ACROSS SCENARIOS
7.1 Low Growth Case
7.2 Reference Growth Case
7.3 High Growth Case
8. NEGLECTED TROPICAL DISEASES DIAGNOSIS COMPANY PROFILES
8.1 Profiles of Leading Neglected Tropical Diseases Diagnosis Companies in the Market
8.2 Business Descriptions, SWOT Analysis, and Growth Strategies
8.3 Financial Performance and Key Metrics
Abbott
Coris BioConcept
DiaSys Diagnostic Systems GmbH
F. Hoffmann-La Roche Ltd
Genome Diagnostics Pvt Ltd
InBios International Inc
Omega Diagnostics Group PLC
Oscar Medicare Pvt Ltd
Thermo Fisher Scientific Inc
ZeptoMetrix
9. APPENDIX
9.1 Scope of the Report
9.2 Research Methodology and Data Sources
9.3 Glossary of Terms
9.4 Market Definitions
9.5 Contact Information
